Vanessa de Souza Valim
Research Subjects
Vanessa de Souza Valim has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Aparecida Paz
Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903, Brazil
1 shared publication - Alice Dahmer Gonçalves1 shared publication
- Aline Fatima Paz1 shared publication
- Annelise Martins Pezzi da Silva1 shared publication
- Bruna Amorin1 shared publication
- Bruna Pochmann Zambonato1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Brazilian Journals in Brazilian Journal of Health Review
- Vol. 8 (5) , e83022
Characterization of very early circulating Natural Killer cells after hematopoietic stem cells transplantation
Natural Killer cells are the first lymphocyte subpopulation to reconstitute after hematopoietic stem cell transplantation. Peripheral blood samples from thirteen patients who underwent allogeneic and autologous hematopoietic stem cell transplantation were analyzed at days 7, 14, 21 and 28 (± 2) after transplantation. Peripheral blood mononuclear cells were isolated using the Bulk Lysis™ EuroFlow standard operating protocol. They were stained for membrane markers with anti-CD45, anti-CD56, anti-CD16, anti-CD3, anti-CD14, anti-CD19, anti-CD2 and anti-CD7; and for intracellular cytokine detection with anti-IL-3, anti-GM-CSF and anti-TGF-1β. On day 7, the presence of Natural Killer cells was detected in 9 patients (mean: 11.6%, SD±: 6.3 of lymphocytes) as well as on day 14 (mean: 16.3%, SD±: 8.2), day 21 (mean: 31.6%, SD±: 9.5) and day 28 (mean: 22.7%, SD±: 6.1). An increase in CD56+16+ phenotype recovery was observed at days 21 (mean: 22%, SD±: 7.2 of lymphocytes, range: 8.0 – 36.1) and 28 (mean: 16%, SD±: 4.9, range: 6.6 – 25.7) when it was compared with CD56bright and CD56+16- (p<0.05). The production of cytokines IL-3, GM-CSF and TGF-β1 was observed during the recovery period of Natural Killer cells within 28 days after transplantation (p=0.04). These data suggest that Natural Killer cells have the ability to produce hematopoietic growth factors and related cytokines which may contribute to the reestablishment of hematopoiesis after transplantation, prevent graft-versus-host disease and enhance the engraftment.
- 1 September 2025
- Published by Brazilian Journals in Brazilian Journal of Health Review
- Vol. 8 (5) , e83022
Open AccessCharacterization of very early circulating Natural Killer cells after hematopoietic stem cells transplantation
Natural Killer cells are the first lymphocyte subpopulation to reconstitute after hematopoietic stem cell transplantation. Peripheral blood samples from thirteen patients who underwent allogeneic and autologous hematopoietic stem cell transplantation were analyzed at days 7, 14, 21 and 28 (± 2) after transplantation. Peripheral blood mononuclear cells were isolated using the Bulk Lysis™ EuroFlow standard operating protocol. They were stained for membrane markers with anti-CD45, anti-CD56, anti-CD16, anti-CD3, anti-CD14, anti-CD19, anti-CD2 and anti-CD7; and for intracellular cytokine detection with anti-IL-3, anti-GM-CSF and anti-TGF-1β. On day 7, the presence of Natural Killer cells was detected in 9 patients (mean: 11.6%, SD±: 6.3 of lymphocytes) as well as on day 14 (mean: 16.3%, SD±: 8.2), day 21 (mean: 31.6%, SD±: 9.5) and day 28 (mean: 22.7%, SD±: 6.1). An increase in CD56+16+ phenotype recovery was observed at days 21 (mean: 22%, SD±: 7.2 of lymphocytes, range: 8.0 – 36.1) and 28 (mean: 16%, SD±: 4.9, range: 6.6 – 25.7) when it was compared with CD56bright and CD56+16- (p<0.05). The production of cytokines IL-3, GM-CSF and TGF-β1 was observed during the recovery period of Natural Killer cells within 28 days after transplantation (p=0.04). These data suggest that Natural Killer cells have the ability to produce hematopoietic growth factors and related cytokines which may contribute to the reestablishment of hematopoiesis after transplantation, prevent graft-versus-host disease and enhance the engraftment.